Autologous Bone Marrow Stem Cells in Ischemic Stroke.
NCT00535197
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Stroke, Acute
Infarction, Middle Cerebral Artery
Interventions
BIOLOGICAL:
Infusion of autologous CD34+ stem cells into middle cerebral artery
Sponsor
Imperial College London